Advisory Services Network’s ImmuCell ICCC Stock Holding History

Advisory Services Network’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200	Closed	-$1.27K	–	3344
2026 Q1	$1.27K	Buy	+200	New	+$1.28K	﹤0.01%	4263

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Advisory Services Network's ICCC Position: Q2 2026 in Review

Advisory Services Network sold out of ImmuCell (ICCC) in Q2 2026, closing a stake of 200 shares — an estimated $1.27K sold.

Advisory Services Network first reported a position in ICCC in Q1 2026 and held it in 1 quarter. The position peaked at $1.27K in Q1 2026. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Advisory Services Network reported no remaining ImmuCell position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 200 ImmuCell shares in Q2 2026, an estimated $1.27K.
Advisory Services Network first reported a position in ImmuCell in Q1 2026 and held it in 1 quarter.
Advisory Services Network's ImmuCell position peaked at $1.27K in Q1 2026.
31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.